MENU
ANRO
AS OF
Dec 24 closing price
Price
$19.88
Change
+$0.22 (+1.12%)
Capitalization
617.6M
85 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
ANRO
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION

Alto Neuroscience (ANRO) Ownership - Who owns Alto Neuroscience?

Alto Neuroscience Inc is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individuals’ neurobiology to develop personalized and effective treatment options... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
369 South San Antonio Road
Phone
+1 650 200-0412
Employees
63
Web
https://www.altoneuroscience.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
617.6M
P/E Ratio
N/A
Total Cash
137.82M
Projected Growth
N/A
Total Debt
27.52M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
4.44
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

ANRO
Capitalization
618M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
138M
Total Cash/Share
4.44
Total Debt
27.5M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
112M
P/B Ratio
5.54
Cash Flow
N/A
Earnings
-2.3
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
3K
Current Ratio
15.42
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-59.36M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-36.77
Shares Held By Institutions
91.9M
Shares Outstanding - Current
31.1M
Total Liabilities
35.4M
Total Volume MTD
N/A
Value
N/A
Gain YTD
369.976
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
ANRO
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ANRO showed earnings on November 12, 2025. You can read more about the earnings report here.
View AI-Driven Trading for ANRO
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
369 South San Antonio Road
Phone
+1 650 200-0412
Employees
63
Web
https://www.altoneuroscience.com